NCT04723654 Evaluating Wearable Smart Sensors for Continuous Measurement of Vital Signs in ICU Patients
| NCT ID | NCT04723654 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ann & Robert H Lurie Children's Hospital of Chicago |
| Condition | Prematurity |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2018-03-15 |
| Primary Completion | 2028-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2018-03-15 with a primary completion date of 2028-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to develop biocompatible wireless electronic devices that will allow continuous, non-invasive hemodynamic and physiology measurements in the ICU.
Eligibility Criteria
Inclusion Criteria-ICU Population: * Admitted to one of the four ICUs at Lurie Children's or Prentice Women's Hospital * Under 18 years of age Inclusion Criteria-Non-ICU Population * Under 18 years of age * Willing to visit the Center for Autonomic Medicine in Pediatrics (CAMP) for a one time study visit Exclusion Criteria-ICU Population: * A skin abnormality that would potentially increase the risk of device * 18 years of age or older * Determined by an attending physician or bedside care team to be too unstable (patient) or experiencing too much stress (family) Exclusion Criteria-Non-ICU Population: * A skin abnormality that would potentially increase risk of device use * 18 years of age or older
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04723654 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Prematurity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04723654 currently recruiting?
Yes, NCT04723654 is actively recruiting participants. Contact the research team at sslattery@luriechildrens.org for enrollment information.
Where is the NCT04723654 trial being conducted?
This trial is being conducted at Chicago, United States, Chicago, United States.
Who is sponsoring the NCT04723654 clinical trial?
NCT04723654 is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. The trial plans to enroll 500 participants.